8-K filed April 20, 2026, 7:59 PM ET ticker NRC CIK 0000070487

other material confidence high sentiment neutral materiality 0.40

NRC Health declassifies board, formalizes name change; CFO restricted stock amended

NRC HEALTH

Name changed to NRC Health from National Research Corp; 'NRC' ticker unchanged; no shareholder vote required.
Board declassified: all directors will face annual elections; five directors resigned residual terms effective before June 23, 2026 meeting.
Resigning directors: Berwick, Green, Hays, Lockhart, Nunnelly; all seven incumbents nominated for reelection at 2026 annual meeting.
CFO Shane Harrison's restricted stock award (172,000 shares, Sept 2025) amended to permit voting and dividends on unvested shares.
Amended Bylaws set max board size at 12, update meeting/notice deadlines, and formalize Chair position.

item 5.02 item 5.03 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001437749-26-012850
form_type: 8-K
ticker: NRC
cik: 0000070487
company_name: NRC HEALTH
filed_at: 2026-04-20T23:59:59+00:00
discovered_at: 2026-05-14T18:02:33.653620+00:00
generated_at: 2026-05-15T05:24:54.191816+00:00
sec_items: ["5.02", "5.03", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001437749-26-012850
json_url: https://secwatch.observer/filing/0001437749-26-012850.json
markdown_url: https://secwatch.observer/filing/0001437749-26-012850.md
text_url: https://secwatch.observer/filing/0001437749-26-012850.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/0001437749-26-012850-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/70487/000143774926012850/nrc20260409_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

5ff911b33626badf7145ea656bafdabd8c53f61f

NRC HEALTH: Changed corporate name to NRC Health pursuant to amendment to certificate of incorporation (effective 2026-04-15).

On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

6229f8eeef9f110496e09a5c1878dc9728e3c1ae

NRC HEALTH: Adopted amended and restated Bylaws declassifying the Board of Directors and making other changes (effective 2026-04-15).

Also on April 15, 2026, the Company’s Board of Directors (the “Board”) adopted and approved, effective April 15, 2026, amended and restated Bylaws of the Company (as amended and restated, the “A&R Bylaws”).

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

Comparable filings

AEIS

AEIS stockholders approve doubling of authorized shares to 140M and expansion of equity plan to 4.9M shares

ADVANCED ENERGY INDUSTRIES INC May 8, 2026, 7:59 PM ET other_material Items 5.02, 5.07, 5.03, 9.01

same fact type: governance_change same SEC item: 5.02, 5.03, 9.01 same event type: other_material similar materiality

This filing

On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).

Comparable filing

the amendment increases the number of authorized shares of common stock from 70,000,000 shares to 140,000,000 shares. The amendment became effective upon the filing of a Certificate of Amendment to the Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware on May 7, 2026.

Filing page SEC filing

MAN

ManpowerGroup declares $0.72 dividend; shareholders approve equity plan amendment and director removal without cause

ManpowerGroup Inc. May 8, 2026, 7:59 PM ET other_material Items 5.02, 5.03, 5.07, 8.01, 9.01

same fact type: governance_change same SEC item: 5.02, 5.03, 9.01 same event type: other_material similar materiality

This filing

On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).

Comparable filing

the Board of Directors of the Company amended Section 3.3 of Article III of the Company’s Amended and Restated By-Laws (the “ By-Laws Amendment ”) to permit the removal of a director with or without cause by the affirmative vote of two-thirds of the outstanding shares of capital stock of the Company entitled to vote at a meeting of shareholders duly called for such purpose. The effective date of the By-Laws Amendment is May 8, 2026.

Filing page SEC filing

RYZ

Ryerson stockholders approve 1.5M share increase in 2014 incentive plan; director Calhoun departs

Ryerson Holding Corp May 6, 2026, 7:59 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.02, 5.03, 9.01 same event type: other_material similar materiality

This filing

On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).

Comparable filing

On April 30, 2026, at the Annual Meeting, upon the recommendation of the Board, the stockholders of the Company approved a proposal to amend and restate the Company’s Amended and Restated Certificate of Incorporation (the “Amended and Restated Charter”) to provide for the exculpation of certain of the Company’s officers in specific circumstances, as permitted by Delaware law.

Filing page SEC filing

IBM

IBM annual meeting: 2026 LTPP approved, all directors elected, stockholder proposals defeated

INTERNATIONAL BUSINESS MACHINES CORP May 1, 2026, 7:59 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.02, 5.03, 9.01 same event type: other_material similar materiality

This filing

On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).

Comparable filing

Article III, Section 2 of the Company’s By-Laws was amended to decrease the number of directors to thirteen, effective April 28, 2026.

Filing page SEC filing

SNDR

Shareholders approve 19.9M share increase in Omnibus Incentive Plan; bylaw changes adopted

Schneider National, Inc. May 1, 2026, 7:59 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.02, 5.03, 9.01 same event type: other_material similar materiality

This filing

On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).

Comparable filing

On April 30, 2026, the Board of the Company approved Amended and Restated Bylaws of the Company to provide that the lead independent director (if any) may call special meetings of the Board and will act as chair of meetings of the Company’s stockholders and of the Board in the absence, inability, or refusal to act of the Chair of the Board. In addition, in the event of a vacancy in the office of Chair because of death, resignation, removal, disqualification, or otherwise in which the Board does not appoint a successor Chair, the lead independent director (if a lead independent director has been duly elected) or Chief Executive Officer (if no lead independent director has been duly elected) shall be the Chair and assume the duties, responsibilities, and authority of the office of Chair until a successor is appointed by the Board.

Filing page SEC filing

FMC

FMC director Dirk Kempthorne dies; shareholders reject supermajority elimination proposals

FMC CORP April 29, 2026, 7:59 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same fact type: governance_change same SEC item: 5.02, 5.03, 9.01 same event type: other_material similar materiality

This filing

On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).

Comparable filing

stockholders approved certain amendments (the “ Charter Amendments ”) to the Company’s Restated Certificate of Incorporation (the “ Certificate of Incorporation ”).

Filing page SEC filing

IACQ

Irenic Acquisition Corp. closes $220M IPO; trust funded with $220M for business combination

Irenic Acquisition Corp. April 29, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 5.02, 5.03, 9.01 same event type: other_material similar materiality

This filing

On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).

Comparable filing

On April 27, 2026, in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association (the “Amended Charter”), effective the same day.

Filing page SEC filing

CXII

Churchill Capital Corp XII closes upsized $414M SPAC IPO; units trade on Nasdaq

Churchill Capital Corp XII April 29, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 5.02, 5.03, 9.01 same event type: other_material similar materiality

This filing

On April 15, 2026, National Research Corporation (the “Company”) changed its corporate name to NRC Health (the “Name Change”) pursuant to an amendment to the Company’s certificate of incorporation filed with the Delaware Secretary of State and effective on April 15, 2026 (the “Charter Amendment”).

Comparable filing

On April 27, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on April 27, 2026.

Filing page SEC filing

Source: SEC EDGAR

accession 0001437749-26-012850

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.